The 14 most recent market catalysts affecting $A, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 4, 2026
Corporate Catalyst
Neutral
Impact 55
Agilent Technologies Rolls Out Agilent S540MD Slide Scanner System In U.S.
Agilent Technologies has launched its S540MD Slide Scanner System in the U.S. market, a significant step following its FDA clearance. This product introduction expands Agilent's di…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Buy on Agilent Technologies, Raises Price Target to $180
Stifel analyst Daniel Arias has maintained a 'Buy' rating on Agilent Technologies (A) and raised the price target from $170 to $180. This action signals a continued bullish sentime…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on Agilent Technologies, Raises Price Target to $190
Citigroup analyst Patrick Donnelly has maintained a 'Buy' rating on Agilent Technologies (A) and raised the price target from $185 to $190. This action signals continued confidence…
Aug 27, 2026
Market Technicals
Bullish
Impact 55
JP Morgan Maintains Overweight on Agilent Technologies, Raises Price Target to $190
JP Morgan analyst Casey Woodring has maintained an 'Overweight' rating on Agilent Technologies (A) and raised the price target from $180 to $190. This action signals continued conf…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $180
TD Cowen analyst Dan Brennan maintained a 'Buy' rating on Agilent Technologies (A) and raised the price target from $155 to $180. This upward revision in the price target indicates…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Bernstein Maintains Outperform on Agilent Technologies, Raises Price Target to $180
Bernstein analyst Eve Burstein has maintained an Outperform rating on Agilent Technologies and raised the price target from $155 to $180. This analyst upgrade signals a more optimi…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Agilent Technologies, Raises Price Target to $185
RBC Capital's analyst Dan Leonard has maintained an 'Outperform' rating on Agilent Technologies and raised the price target from $155 to $185. This action signals increased confide…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $172
Evercore ISI Group, through analyst Vijay Kumar, has maintained its 'Outperform' rating for Agilent Technologies and raised the price target from $148 to $172. This action signals …
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 92
Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 guidance above estimates. Also, the company issued Q4 sales guidance above estimates.
This headline represents a major positive corporate catalyst for Agilent Technologies. Better-than-expected Q3 results and, more importantly, raised guidance for both Q4 and FY26, …
Aug 26, 2026
Corporate Catalyst
Neutral
Impact 75
Agilent Technologies Sees Q4 Adj EPS $1.71-$1.74 vs $1.72 Est; Sees Sales $1.980B-$2.000B vs $1.971B Est
Agilent Technologies released its Q4 guidance, projecting adjusted EPS between $1.71 and $1.74, which is consistent with the analyst consensus of $1.72. More notably, the company's…
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 92
Agilent Technologies Q3 Adj. EPS $1.62 Beats $1.49 Estimate, Sales $1.878B Beat $1.841B Estimate
Agilent Technologies (A) announced Q3 adjusted EPS of $1.62, significantly exceeding the $1.49 analyst consensus, and sales of $1.878 billion, also beating the $1.841 billion estim…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $175
Morgan Stanley's analyst Kallum Titchmarsh maintained an 'Overweight' rating on Agilent Technologies and raised the price target from $160 to $175. This action signals continued co…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 65
Agilent Technologies shares are trading higher after the company announced it has received EU certification for PD-L1 IHC 22C3 pharmDx, in identifying epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
Agilent Technologies announced it has received EU certification for its PD-L1 IHC 22C3 pharmDx, a diagnostic test used to identify epithelial ovarian, fallopian tube, or primary pe…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 55
Agilent Technologies Receives EU Certification For Code SK006 As Companion Diagnostic To Aid In Identifying Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma
Agilent Technologies received EU certification for its PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic for specific ovarian, fallopian tube, and primary peritoneal ca…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.